XML 38 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Discontinued Operations
12 Months Ended
Dec. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations
Discontinued Operations

At December 31, 2015, Torchmark met the criteria to account for its Medicare Part D Prescription Drug Plan business as a discontinued operation. Historically, the business was a reportable segment. Effective July 1, 2016, Torchmark sold its Medicare Part D Prescription Drug Plan business to an unaffiliated third party.

The sale resulted in a net gain of $1.8 million ($1.2 million net of tax) in 2016. The operating results from discontinued operations are reflected in income for the twelve months ended December 31, 2017. The remaining assets and liabilities reflected on the Torchmark balance sheet related to discontinued operations are receivables and payables associated with the 2016 and prior plan years that are expected to be settled in the ordinary course of business during 2018.

The net assets related to discontinued operations at December 31, 2017 and 2016 were as follows:
 
At December 31,
 
2017
 
2016
Assets:
 
 
 
Due premiums
$
3,945

 
$
8,840

Other receivables(1)
64,575

 
118,692

Total assets related to discontinued operations
68,520

 
127,532

 
 
 
 
Liabilities:
 
 
 
Risk sharing payable
8,731

 
8,374

Current and deferred income taxes payable
1,077

 
3,820

Other(2)
40,046

 
15,230

Total liabilities related to discontinued operations
49,854

 
27,424

 
 
 
 
Net assets
$
18,666

 
$
100,108


(1)
At December 31, 2017, other receivables included $65 million from Centers for Medicare and Medicaid Services (CMS). At December 31, 2016, the comparable amounts were $50 million from CMS and $69 million from drug manufacturer rebates.
(2)
At December 31, 2017, the balance included $37.3 million due to CMS. At December 31, 2016, the balance includes $3.6 million contingent sale price reserve.

Income from discontinued operations for the three years ended December 31, 2017 is as follows:
 
Year Ended December 31,
 
2017
 
2016
 
2015
Revenue:
 
 
 
 
 
Health premium
$

 
$
222,840

 
$
260,657

 
 
 
 
 
 
Benefits and expenses:
 
 
 
 
 
Health policyholder benefits
3,827

 
183,423

 
213,114

Amortization of deferred acquisition costs

 
3,747

 
3,506

Commissions, premium taxes, and non-deferred acquisition expenses
763

 
16,396

 
20,909

Other operating expense
1,209

 
5,377

 
6,502

Total benefits and expenses
5,799

 
208,943

 
244,031

 
 
 
 
 
 
Income before income taxes for discontinued operations
(5,799
)
 
13,897

 
16,626

Gain from sale of discontinued operations

 
1,779

 

Income taxes
2,030

 
(5,487
)
 
(5,819
)
Income from discontinued operations
$
(3,769
)
 
$
10,189

 
$
10,807

 
Income taxes paid related to discontinued operations for the three years ended December 31, 2017 were as follows:
 
Year Ended December 31,
 
2017
 
2016
 
2015
Income taxes paid
$
714

 
$
15,271

 
$
3,409